Compression in Postural Tachycardia Syndrome: Exploring the Patient Experience
Summary
This study is looking at experiences with compression garments in individuals diagnosed with POTS. Many doctors prescribe compression garments for POTS, but there is little research demonstrating if they actually work. The theory behind a compression garment is that it ‘squeezes’ the blood vessels in the legs and pelvis/abdomen, making it easier for blood to get back to your heart when you are standing. This improved blood return may mean that your heart does not need to beat as fast. However, there is also no research looking at the patient experience with compression garments.
In this study, you will participate in a phone interview that will last approximately 20 minutes but may be slightly shorter or longer. This will be a one on one interview with a member of the research team. We will ask you questions about compression garments, and your experience with wearing or not wearing them as a management option for your POTS symptoms. We plan to interview both participants who have/do wear compression garments as well as those who have not worn a compression garment.
Eligibility
Eligible ages: 18 to 60
Inclusion criteria:
1. Physician diagnosis of Postural Tachycardia Syndrome (POTS)
2. Canadian resident
3. Age 18-60 years
4. All genders
5. Able and willing to provide informed consent
6. Ability to participate in a phone interview
7. Both participants who have or have not worn compression garments for their POTS symptoms
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Principal Investigator: Dr. Satish Raj Co-Investigator: Dr. Mary Runte Study Coordinator: Kate Bourne
Principal investigator:
Satish Raj
Clinical trial:
No
REB-ID:
REB18-1824